Literature DB >> 12871549

Fibrinogen gamma' chain binds thrombin exosite II.

R S Lovely1, M Moaddel, D H Farrell.   

Abstract

A high-affinity thrombin-binding site in an alternately processed fibrinogen variant, the gammaA/gamma' isoform, is characterized in this report. The binding site has been shown to be situated between gamma' 414 and 427, and Tyr418 and 422 in this part of the gamma' chain are known to be sulfated. A synthetic peptide corresponding to the gamma' chain carboxyl terminus is shown to bind thrombin with a Kd = 0.63 +/- 0.16 micro mol L-1. Maximum binding of this peptide requires negative charges on Tyr418 and 422. Competitive binding studies with hirudin peptides, heparin and DNA aptamers specific for thrombin exosites I or II indicate thrombin binds to the gamma' peptide via exosite II. Thus, thrombin binding to the gamma' chain leaves exosite I and the active site accessible to substrates. This may explain why fibrin-bound thrombin can retain enzymatic activity, and why fibrin-bound thrombin is heparin-resistant.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871549     DOI: 10.1046/j.1538-7836.2003.00027.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  24 in total

1.  Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease.

Authors:  Rehana S Lovely; Steven C Kazmierczak; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; David H Farrell
Journal:  Clin Chem       Date:  2010-03-26       Impact factor: 8.327

2.  Association between γ' fibrinogen levels and inflammation.

Authors:  Kristine S Alexander; Theresa E Madden; David H Farrell
Journal:  Thromb Haemost       Date:  2010-12-21       Impact factor: 5.249

3.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

4.  Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

5.  Long range communication between exosites 1 and 2 modulates thrombin function.

Authors:  Nicolas S Petrera; Alan R Stafford; Beverly A Leslie; Colin A Kretz; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

6.  Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.

Authors:  Laura M Haynes; Thomas Orfeo; Kenneth G Mann; Stephen J Everse; Kathleen E Brummel-Ziedins
Journal:  Biophys J       Date:  2017-04-25       Impact factor: 4.033

7.  Role of electrostatic interactions in binding of thrombin to the fibrinogen γ' chain.

Authors:  Kristine S Alexander; Michael G Fried; David H Farrell
Journal:  Biochemistry       Date:  2012-04-15       Impact factor: 3.162

8.  Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis.

Authors:  Jeffrey N Harr; Ernest E Moore; Theresa L Chin; Arsen Ghasabyan; Eduardo Gonzalez; Max V Wohlauer; Angela Sauaia; Anirban Banerjee; Christopher C Silliman
Journal:  Shock       Date:  2014-01       Impact factor: 3.454

9.  Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces.

Authors:  Shu Zhu; Yichen Lu; Talid Sinno; Scott L Diamond
Journal:  J Biol Chem       Date:  2016-09-07       Impact factor: 5.157

10.  Ligand binding to anion-binding exosites regulates conformational properties of thrombin.

Authors:  Marina V Malovichko; T Michael Sabo; Muriel C Maurer
Journal:  J Biol Chem       Date:  2013-02-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.